Skip to content

Comparison of Erector Spina Plane Block and Thoracic Epidural Block

Comparison of Erector Spina Plane Block and Thoracic Epidural Block in Breast Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04702061
Enrollment
20
Registered
2021-01-08
Start date
2021-01-11
Completion date
2021-03-31
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Pain, Postoperative

Brief summary

The aim of this randomised controlled and double-blind study, is to compare the effects of erector spinae plane (ESP) and thoracic epidural (TEA) blocks on peri-operative hemodynamics and analgesia in patients undergoing unilateral mastectomies due to malignancy.

Detailed description

Patients will be randomised into two groups as Group E (those who received general anesthesia after the erector spina plan block) and Group T (those who received general anesthesia after thoracic epidural block). After the block skin conductivity (galvanic skin response - GSR), body temperature changes, sympathetic and sensory block levels, peri-operative hemodynamic data, postoperative pain scores and analgesic consumption will be recorded.

Interventions

OTHERErector spina plane block before general anaesthesia

After skin infiltration with 2 ml of 2% lidocaine, an 18 G tuohy needle will be directed between the erector spina muscle and the transverse process of the T4 vertebra using the in-plane technique. The location of the needle will be confirmed by hydrodissection with saline after touching the transverse process. After the plan open, 5 ml of 2% lidocaine, 10 ml of 0.5% bupivacaine and 10 ml of saline, including hydrodissection, will be given in a total amount of 25 ml. Then a 20-G epidural catheter will be inserted 3-4 cm and fixed.

OTHERThoracic epidural block before general anaesthesia

After skin infiltration with 2 ml of 2% lidocaine, an 18 G tuohy needle will be entered through the T4-5 interspinous space (median or paramedian approach). After reaching the thoracic epidural area by loss of resistance method, the epidural catheter will be advanced and fixed to remain 3-4 cm in the epidural area. Following the test dose (2 ml of 2% lidocaine), 3 ml of 2% lidocaine, 5 ml of 0.5% bupivacaine and 5 ml of saline will be administered intermittently in a total volume of 15 ml.

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA(American Society of Anesthesiologist) physical classification I-III * Patients undergoing unilateral mastectomies due to malignancy

Exclusion criteria

* Active infection at the intervention site * History of coagulopathy or anticoagulant use (less time has passed before peripheral and central blocks) * Major cardiac, pulmonary, renal and neurological diseases * Autonomic neuropathy or use of drugs that affect autonomic function * Patients with type 1 diabetes or insulin dependent type 2 diabetes over 10 years * Allergic to local anesthetics; * Patients who are uncooperative or have psychiatric problems * Morbidly obese (body mass index \> 35 kg/m2)

Design outcomes

Primary

MeasureTime frameDescription
Sensorial block level evaluation45 minutes after block administrationBy pin-prick test
Sympathetic block level evaluation with skin temperature45 minutes after block administrationSkin temperature of bilateral thorax will be measured
Sympathetic block level evaluation with hot cold test45 minutes after block administrationHot cold test of bilateral thorax will be measured
Sympathetic block level evaluation by hemodynamic data45 minutes after block administrationPeri-operative heart rate and mean arterial pressure will be recorded
Sympathetic block level evaluation with skin conductivity45 minutes after block administrationSkin conductivity will be measured by galvanic skin response (GSR)

Secondary

MeasureTime frameDescription
Postoperative pain scores24 hours after operationPain score will be measured with visual analog scale (0-no pain; 10-worst pain) during movement and rest.
Rescue analgesics consumptionDuring the operation and 24 hours after operationAmount of remifentanil (microgram)
intraoperative hemodynamic dataDuring the operationHeart rate and mean arterial pressure

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026